Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 15,360 shares at $29.01 ($444K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Scheduled sale ($444k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.64 | 2,237 | $64K | 14.4% |
| 2 | $28.64 | 2,237 | $64K | 14.4% |
| 3 | $29.01 | 5,443 | $158K | 35.6% |
| 4 | $29.01 | 5,443 | $158K | 35.6% |
| Total | $28.90 avg | 15,360 | $444K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |